Cardiorenal syndromes: pathogenetic, clinicodiagnostic, prognostic and therapeutic aspects
- Authors: Moiseev V.S.1,2, Kobalava Z.D.1,2, Moiseev VS3,4, Kobalava Z.D3,4
-
Affiliations:
- Российский университет дружбы народов
- городская клиническая больница № 64
- Russian University of Peoples' Friendship
- Moscow City hospital N 64
- Issue: Vol 83, No 12 (2011)
- Pages: 5-11
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30914
- ID: 30914
Cite item
Full Text
Abstract
About the authors
Valentin Sergeevich Moiseev
Российский университет дружбы народов; городская клиническая больница № 64проф., акад. РАМН, зав. каф. факультетской терапии РУДН, руководитель терапевтической клиники ГКБ № 64, тел.: 8-499-134-83-06; Российский университет дружбы народов; городская клиническая больница № 64
Zhanna Davidovna Kobalava
Российский университет дружбы народов; городская клиническая больница № 64проф., зав. каф. пропедевтики внутренних болезней РУДН, ГКБ № 64, тел.: 8-499-134-65-91; Российский университет дружбы народов; городская клиническая больница № 64
V S Moiseev
Russian University of Peoples' Friendship; Moscow City hospital N 64Russian University of Peoples' Friendship; Moscow City hospital N 64
Zh D Kobalava
Russian University of Peoples' Friendship; Moscow City hospital N 64Russian University of Peoples' Friendship; Moscow City hospital N 64
References
- Berbary A. Links between CKD and cardiovascular disease. In: Berbary A., Mancia G. eds. Cardiorenal syndrome. 2010. 3. a.
- Моисеев B. C., Мухин H. A., Кобалава Ж. Д. и др. Функциональное состояние почек и прогнозирование сердечно-сосудистого риска. Рекомендации Всероссийского научного общества кардиологов и научного общества нефрологов. Клин. фармакол. и тер. 2009; 4: 1-8.
- Ronco С. The cardiorenal syndrome: basis and common ground for a multidisciplinary patient-oriented therapy. Cardio Renal Med. 2011; 1 (1): 3-4.
- Chan E., Dellsperger K. Cardiorenal syndrome: the clinical cardiologists perspective. Cardio Renal Med. 2011; 1 (1): 13-22.
- Adams K., Fonarow G., Emerman С. et al. ADHERE Investigators: Characteristics and outcomes of patients hospitalized for heart failure in the US. Am. Heart J. 2005; 149: 209.
- Fonarow G., Adams K., Abraham W. et al. Risk stratification hospital mortality in acutely decompensated heart failure. J. A. M. A., 2005; 293: 572.
- Koreny M., Karth G., Geppert A. et al. Prognosis of pts who develop acute renal failure during the first 24 hours of cardiogenic shock after MI. Am. J. Med. 2002; 112: 115.
- Braunwald E., Libby P., Bonow R. et al. Braunwald's heart disease. Philadelphia: Saunders; 2008.
- Ronco C., House A., Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34: 957.
- Sandler С. Contrast agent induced acute renal dysfunction - is iodixanol the answer? N. Engl. J. Med. 2003; 348: 551.
- Rudnick M., Goldfarb S., Wexler L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 pts. The iohexol study. Kidey Int. 1995; 47: 254.
- Mehran R., Aymong E., Nikolsky E. et al. A simple risk score for prediction of contrast-induced nephropathy after coronary intervention. J. Am. Coll. Gardiol. 2004; 44: 1393.
- Nohria A., Hasselblad V., Stebbins A. et al. Cardiorenal interactions: insights from the ESCAPE trial. J. Am. Coll. Gardiol. 2008; 51: 1268.
- Binanay С., Califf R., Hasselblad V. et al. Evaluation study of heart failure and pulmonary artery catheterisation effectiveness: the ESCAPE study. J. A. M. A. 2005; 294: 1625.
- Bock J., Gotlieb S. Cardiorenal syndrome: new perspective. Circulation 2010; 121: 2592.
- Mishra J., Ma Q., Prada A. et al. Identification of lipocalin as a novel urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 2003; 14: 2534.
- Herget-Rosental S., Marggraf G., Husing J. et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004; 66: 1115.
- Coresh J., Astor В., Greene T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult population. Am. J. Kidney Dis. 2003; 41: 1-12.
- Tonelly M., Wiebe N., Culleton B. et al. Chronic kidney disease and mortality risk. J. Am. Soc. Nephrol. 2006; 17: 2034.
- Hideki Kawai, Masayoshi Sarai, Hiroto Harigaya. Impact of coronary atherosclerosis in Japanese women with chronic kidney disease. J. Am. Coll. Cardiol. 2011; 57 (14): E354.
- Baber U., Mehran R., Weisz G. Differences in coronary plaque composition and morphology in patients with and without chronic kidnet disease presenting with acute coronary syndromes: insights from the prospect study. J. Am. Coll. Cardiol. 2011; 57 (15): E1442.
- Lekawanvijit U., Kompa A., Manabе M., Kelly D. J. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sylfate. J. Am. Coll. Cardiol. 2011; 57 (17): 914.
- Ashrith G., Lee V., Elayda M. et al. Outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multyvessel disease in pts with chronic kidney failure. Am. J. Cardiol. 2010; 106: 348.
- Culleton В., Walsh M., Klarenbach S. et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. J. A. M. A. 2007; 298: 1291.
- Morial E. Continuous deteriorated kidney function after coronary intervention is strongly associated with an increased of long term mortality. J. Am. Coll. Cardiol. 2011; 57 (14): E1890.
- Herzog C., Li S., Weinhandl E. et al. Survival of dialysis pts after cardiac arrest and the impact of cardioverter defibrillators. Kidney Int. 2005; 68: 818.
- Rubin M., Towensend R. Stroke. ln: Berbary A., Mancia G., eds. Cardiorenal syndrome. J. Am. Coll. Cardiol. Springer; 2010. 205.
- Bahous S., Delahousse M., Safar M. Aortic stiffness, kidney disease and transplantation. In: Berbary A., Mancia G., eds. Cardiorenal syndrome. Springer; 2010. 255.
- London G., Pannier В., Marchais S. Disturbed calcium-phosphorus metabolisml arterial calcificatios. In: Berbary A., Mancia G., eds. Cardiorenal syndrome. Springer; 2010. 269.
- Ritz E. Management of pts with chronic kidney disease and cardiovascular disease. In: Berbary A., Mancia G., eds. Cardiorenal syndrome. Springer; 2010. 359.
- Mallamaci F., Leonardi D., Borrajo M. Role of novel biomarkers in chronic kidney disease: urotensin II. In Berbary A., Mancia G., eds. Cardiorenal syndrome. Springer; 2010. 299.
- Кутырина И. М., Савельева С. А., Крячкова А. А. и др. Вклад ожирения в поражение почек у больных сахарным диабетом 2-го типа. Тер. арх. 2010; 6: 21-25.
- Flynn C., Bakris G. Interaction between adiponectin and aldosterone. Cardiorenal Med. 2011; 1: 96-101.
- Liang K., Williams A., Greene E. et al. Acute decompensated heart failure and cardiorenal syndrome. Crit. Care Med. 2008; 36 (Suppl. 1): 75.
- Singh D. Insufficient natriuretic response to furosemide predicts worsening renal function in acute decompensated heart failure independent of baseline renal function. J. Am. Coll. Cardiol. 2011; 57 (17): 1017.
- Sackner-Bernstein J., Scopicki H., Aaronson K. Risk of worsening renal function with nesiritide in pts with heart failure. Circulation 2005; 111: 1487.
- Cotter G., Dittrich H., Weatherley B. et al. The PROTECT study: a study of the adenosine A1 receptor antagonist rolofylline in pts with acute heart failure and renal impairment. J. Card. Fail. 2008; 14: 631.
- Konstam M., Gheorgiade M., Burnett J. et al. Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators. J. A. M. A. 2007; 297: 1319.
- Guyton A. C., Hall J. E. Textbook of medical physiology. New York: Saunders; 2000.
- Ronco C., Haapio M., House A. A. et al. Cardiorenal syndrome. J. Am. Coll. Cardiol. 2008; 52: 1527-1539.
- Ronco C., McCullough P., Anker S. D. et al. Acute Dialysis Quality Initiative (ADQI) consensus group: Cardiorenal syndromes: report from the consensus conference of the acute dialysis and quality initiative. Eur. Heart. J. 2010; 31: 703-711.
- Ronco C. The cardiorenal syndrome: Basis and common ground for a multidisciplinary patient-oriented therapy. Cardiorenal. Med. 2011; 1: 3-4.